跳至主要内容
临床试验/NCT05331313
NCT05331313尚未招募不适用

Analysis of Genomic Alterations in Sporadic Cases of Multiple Myeloma

Hospices Civils de Lyon1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2022年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
1,000
试验地点
1
主要终点
DNA mutations associated with the existence of multiple myeloma

研究概览

简要总结

There is a growing body of data suggesting that the the risk of developing multiple myeloma, or myelomagenesis, is associated with genetic alterations occurring in the tumor cells. A limited number of candidate genes and polymorphisms have been reported in patients with this disease. In this study the investigators will compare the genetic information obtained on purified abnormal plasmocytes obtained from patients with multiple myeloma with available public databases in an effort to identify and if possible validate the role of certain mutations and/or polymorphisms in myelomagenesis. Plasmocytes will be obtained by immunomagnetic enrichment using CD138+ beads.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • diagnosis of multiple myeloma
  • availability of abnormal plasmocytes

排除标准

  • 未提供

结局指标

主要结局

DNA mutations associated with the existence of multiple myeloma

时间窗: through study completion, an average of 1 year

DNA data acquired in myeloma patient samples will be compared to those of healthy subjects using publically available databases.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验